What is the price target for RBOT stock?
6 analysts have analysed RBOT and the average price target is 5.1 USD. This implies a price increase of 165.63% is expected in the next year compared to the current price of 1.92.
VICARIOUS SURGICAL INC-A (RBOT) Forecast, Price Target & Analyst Ratings
NYSE:RBOT • US92561V2088
Current stock price
1.92 USD
-0.12 (-5.88%)
At close:
1.98 USD
+0.06 (+3.13%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VICARIOUS SURGICAL INC-A (RBOT).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 16, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$1.40
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$5.10
Upside
+ 165.63%
From current price of $1.92 to mean target of $5.10, Based on 6 analyst forecasts
Low
$5.05
Median
$5.10
High
$5.25
Price Target Revisions
1 Month
0.00%
3 Months
-44.44%
Price Target Summary
6 Wall Street analysts provided a forecast for the next 12 months for RBOT. The average price target is 5.1 USD. This implies a price increase of 165.63% is expected in the next year compared to the current price of 1.92.
The average price target has been revised downward by 44.44% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
RBOT was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about RBOT.
In the previous month the buy percentage consensus was at a similar level.
RBOT was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-08-13 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-03-18 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-11-13 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-08-13 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-07-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-03-05 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-12-04 | Morgan Stanley | Initiate | Equal-Weight |
| 2023-11-14 | BTIG | Downgrade | Buy -> Neutral |
| 2023-11-14 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2023-05-31 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2022-07-18 | BTIG | Maintains | Buy |
| 2022-05-10 | Piper Sandler | Maintains | Neutral |
| 2022-03-04 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2022-01-07 | Credit Suisse | Initiate | Outperform |
| 2021-12-07 | Cowen & Co. | Initiate | Outperform |
| 2021-11-05 | Canaccord Genuity | Initiate | Buy |
| 2021-10-18 | BTIG | Initiate | Buy |
| 2021-10-07 | Piper Sandler | Initiate | Overweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 16, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$1.40
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 40.79%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
4.86%
Next Earnings Summary
RBOT is expected to report earnings on 3/16/2026. The consensus EPS estimate for the next earnings is -1.4 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2025 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 21.81M | 13.848M -36.51% | -100.00% | 18.768M | 21.624M 15.22% | 65.79M 204.25% | 134.44M 104.35% | |||
| EBITDA YoY % growth | -78.97M -108.36% | -78.812M 0.20% | -64.448M 18.23% | -33.66M 47.77% | -33.66M | -8.16M 75.76% | N/A | N/A | N/A | |
| EBIT YoY % growth | -80.08M -109.52% | -80.666M -0.73% | -66.555M 17.49% | -61.2M 8.05% | -69.36M -13.33% | -51M 26.47% | N/A | N/A | N/A | |
| Operating Margin | N/A | -369.85% | -480.62% | N/A | N/A | -271.74% | N/A | N/A | N/A | |
| EPS YoY % growth | -13.50 26.47% | -14.70 -8.89% | -10.85 26.19% | -8.25 23.95% | -4.15 49.69% | -3.39 18.30% | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.40 40.79% | -1.22 52.92% | -1.17 47.40% | -1.12 39.68% | -0.62 55.47% | -0.36 70.83% | -0.51 56.52% | -0.67 40.00% | -0.68 -9.84% |
| Revenue Q2Q % growth | 3.06M | 4.284M | 5.712M | 5.814M | |||||
| EBITDA Q2Q % growth | -8.16M 36.60% | -8.16M 46.94% | -8.16M 35.93% | -8.16M 21.30% | -8.16M | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -15.3M -2.15% | -17.34M -10.12% | -17.34M -28.26% | -17.34M -50.74% | -17.34M -13.33% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
19.05%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
23.49%
EBIT Next 5 Year
N/A
VICARIOUS SURGICAL INC-A / RBOT Forecast FAQ
When does VICARIOUS SURGICAL INC-A (RBOT) report earnings?
VICARIOUS SURGICAL INC-A (RBOT) will report earnings on 2026-03-16, after the market close.
What are the consensus estimates for RBOT stock next earnings?
The consensus EPS estimate for the next earnings of VICARIOUS SURGICAL INC-A (RBOT) is -1.4 USD and the consensus revenue estimate is 0 USD.